Search Result "myeloproliferative disease"
Chronic Myeloproliferative Diseases
Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Katia B. Barbosa Pagnano
Doi: 10.2174/978160805259211201010193
Acute Myeloproliferative Disease
Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Eduardo Magalhaes Rego,Mariana Tereza de Lira Benicio
Doi: 10.2174/978160805259211201010201
JAK2 as a Molecular Marker in Myeloproliferative Diseases
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 198-203
Author(s): R. Mata, D. Subira, A. Garcia-Raso, P. Llamas
Myelodysplastic/Myeloproliferative Neoplasms
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 52-65
Author(s): Cherie H. Dunphy
Immunotherapy for Myeloproliferative Neoplasms (MPN)
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 72-84
Author(s): Susanne Hofmann, Anna Babiak, Jochen Greiner
Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 17 Issue: 3 Year: 2017 Page: 161-166
Author(s): Habib Haybar,Elahe Khodadi,Mohammad Shahjahani,Najmaldin Saki
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 14-29
Author(s): Robert P. Hasserjian
Molecular Pathogenesis of Philadelphia Chromosome Negative Chronic Myeloproliferative Neoplasms
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 20-30
Author(s): R. Jager, R. Kralovics
Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke
Journal: Current Neurovascular Research
Volume: 14 Issue: 3 Year: 2017 Page: 222-231
Author(s): Chih-Cheng Chen,Chia-Chen Hsu,Cih-En Huang,Yi-Yang Chen,Jrhau Lung,Hsing-Ying Ho,Chian-Pei Li,Jiann-Der Lee
Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek